NFE2L2 and neoplasm: In lung, pancreatic as well as colorectal cancer cells, activation of NRF2 may enhance tumor cell proliferation and/or confers resistance to various chemotherapies8, 9, 10, 11, 23, 24, 25, 26, 27, 28, 29.